Loading
Logo
Get in Touch

Product Details

Mazdutide
<
>
Mazdutide
Mazdutide

// Quality First, Safety Guaranteed.

Mazdutide

Lithium Hydroxide


Mazdutide

Basic Info.


Mazdutide is a dual  agonist  of the GLP-1receptor and glucagon receptor. It is an analog of oxyntomodulin (OXM). 

The drug is developed by Eli Lilly and is currently in multiple Phase III studies.


 In May 2025, a result of Phase III study has shown that once-weekly mazdutide led to clinically relevant reductions in body weight in Chinese adults with overweight or obesity.


Areas of Expertise

  • Check icon Leading-Edge Manufacturing Capabilityg
  • Check icon Advanced R&D and State-of-the-Art Facilities
  • Check icon Versatile and Scalable Packaging Solutions
  • Check icon Certified Quality & International Compliance
Previous image
< Previous
Cagrilintide
Next >
NAD
Next image

Leave a message

Happy to answer all your questions.